drugset / Trial / NCT00141362

Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain.

NCT00141362

Phase 3 Completed 325 enrolled Pfizer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Evaluate long-term safety and efficacy of pregabalin in patients with chronic neuropathic pain.

Timeline

Start
2001-10
Primary completion
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule

Indications

No indication recorded.